Abstract: We describe a detection module useful with an apparatus and/or system for conducting luminescence assays, and a kit, a system, an apparatus, and a method incorporating the detection module.
Type:
Grant
Filed:
November 16, 2020
Date of Patent:
April 30, 2024
Assignee:
Meso Scale Technologies, LLC.
Inventors:
Charles M. Clinton, Jacob N. Wohlstadter
Abstract: The present invention relates to methods of diagnosing glomerulonephritis (GN) in a patient, as well as methods of monitoring the progression of GN and/or methods of monitoring a treatment protocol of a therapeutic agent or a therapeutic regimen. The invention also relates to assay methods used in connection with the diagnostic methods described herein.
Type:
Grant
Filed:
February 8, 2021
Date of Patent:
April 30, 2024
Assignee:
Meso Scale Technologies, LLC.
Inventors:
Eli N. Glezer, John Kenten, Galina Nikolenko
Abstract: Methods and kits to assess an absorbed dose of ionizing radiation and/or the severity of tissue injury from radiation in a patient. Also, algorithms used to calculate an absorbed dose of radiation based on biomarker measurements of a plurality of biomarkers that are altered relative to a normal control in the event of radiation exposure.
Type:
Grant
Filed:
February 22, 2018
Date of Patent:
April 23, 2024
Assignees:
Meso Scale Technologies, LLC, THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.
Inventors:
William F Blakely, Eli N. Glezer, John Kenten, Sudeep Kumar, Anu Mathew, Natalia I. Ossetrova, George Sigal
Abstract: In examples, a method of controlling customer access to an assay system comprises (a) receiving a system identifier; (b) identifying said system identifier; and (c) utilizing information obtained from the system identifier to perform one or more operations selected from: (i) enabling full access to said system and/or a consumable used in said system; (ii) enabling partial access to said system and/or a consumable used in said system; or (iii) denying access to said system and/or a consumable used in said system.
Type:
Grant
Filed:
March 17, 2023
Date of Patent:
April 16, 2024
Assignee:
Meso Scale Technologies, LLC.
Inventors:
Xinri Cong, Jerome Jackson, Carl Stevens, Michael Vock, Jacob N. Wohlstadter
Abstract: The invention relates to methods for conducting solid-phase binding assays. One example is an assay method having improved analyte specificity where specificity is limited by the presence of non-specific binding interactions.
Type:
Grant
Filed:
March 29, 2021
Date of Patent:
April 9, 2024
Assignee:
MESO SCALE TECHNOLOGIES, LLC.
Inventors:
Eli N. Glezer, Sudeep Kumar, Pankaj Oberoi, George Sigal, Michael Tsionsky
Abstract: We describe apparatuses, systems, method, reagents, and kits for conducting assays as well as process for their preparation. They are particularly well suited for conducting automated sampling, sample preparation, and analysis in a multi-well plate assay format. For example, they may be used for automated analysis of particulates in air and/or liquid samples derived therefrom in environmental monitoring.
Type:
Grant
Filed:
February 7, 2019
Date of Patent:
March 26, 2024
Assignee:
Meso Scale Technologies, LLC.
Inventors:
Charles M. Clinton, Eli N. Glezer, Sharon West, George Sigal, Carl Stevens, Michael L. Vock
Abstract: The present disclosure provides compositions, reagents, kits, systems, system components, and methods for performing assays. More particularly, the disclosure relates to an assay composition for detecting luminescence, which comprises an alkyl diethanolamine, for example, N-butyldiethanolamine (BDEA). In emodiments, the assay composition comprises 2-dibutylaminoethanol (BDAE).
Type:
Grant
Filed:
July 20, 2022
Date of Patent:
March 12, 2024
Assignee:
MESO SCALE TECHNOLOGIES, LLC.
Inventors:
Alexander K. Tucker-Schwartz, George Sigal
Abstract: The present invention relates to methods of diagnosing a kidney disorder in a patient, as well as methods of monitoring the progression of a kidney disorder and/or methods of monitoring a treatment protocol of a therapeutic agent or a therapeutic regimen. The invention also relates to assay methods used in connection with the diagnostic methods described herein.
Type:
Application
Filed:
March 27, 2023
Publication date:
February 15, 2024
Applicant:
Meso Scale Technologies, LLC.
Inventors:
Eli N. Glezer, John Kenten, Sudeep Kumar, Galina Nikolenko
Abstract: Apparatuses, systems, method, reagents, and kits for conducting assays as well as process for their preparation are described. The apparatuses, systems, method, reagents, and kits may be employed in conducting automated analysis in a multi-well plate assay format.
Type:
Grant
Filed:
July 15, 2020
Date of Patent:
February 13, 2024
Assignee:
MESO SCALE TECHNOLOGIES, LLC.
Inventors:
Gary I. Krivoy, Cecilia Zimmerman, Jules Vandersarl, Sandor Kovacs, Aaron H. Leimkuehler, Leo Tabakin, Jon Willoughby, Manish Kochar, Charles M. Clinton
Abstract: Assay cartridges are described that have purification, reaction, and detection zones and other fluidic components which can include sample chambers, waste chambers, conduits, vents, reagent chambers, reconstitution chambers and the like. The assay cartridges are used to conduct multiplexed nucleic acid measurements. Also described are kits including such cartridges, methods of using the same, and a reader configured to analyze an assay conducted using an assay cartridge.
Type:
Grant
Filed:
September 25, 2020
Date of Patent:
February 13, 2024
Assignee:
MESO SCALE TECHNOLOGIES, LLC.
Inventors:
Eli N. Glezer, Stephen Higgins, Sandor Kovacs, Sudeep Kumar, Kenneth Page, Kristian Roth, George Sigal
Abstract: We describe apparatuses, systems, method, reagents, and kits for conducting assays as well as process for their preparation. They are particularly well suited for conducting automated sampling, sample preparation, and analysis in a multi-well plate assay format. For example, they may be used for automated analysis of particulates in air and/or liquid samples derived therefrom in environmental monitoring.
Type:
Grant
Filed:
October 1, 2020
Date of Patent:
February 6, 2024
Assignee:
Meso Scale Technologies, LLC.
Inventors:
Charles M. Clinton, Eli N. Glezer, Bandele Jeffrey-Coker, Sandor L. Kovacs, Sudeep M. Kumar, George Sigal, Carl Stevens, Michael Vock
Abstract: The present invention relates to methods of diagnosing lung cancer in a patient, as well as methods of monitoring the progression of lung cancer and/or methods of monitoring a treatment protocol of a therapeutic agent or a therapeutic regimen. The invention also relates to assay methods used in connection with the diagnostic methods described herein.
Type:
Application
Filed:
October 4, 2023
Publication date:
January 25, 2024
Applicant:
Meso Scale Technologies, LLC.
Inventors:
Anahit Aghvanyan, Eli N. Glezer, John Kenten, Sudeep Kumar, Galina Nikolenko, Martin Stengelin, Srikant Vaithilingam
Abstract: The application is directed to a device housing. The device housing includes a first light device, the first light device including a first electrical supply configured to provide an electrical signal to a first light emitting diode (LED), the first LED separated from a first surface of a diffuser film by a space, wherein the diffuser film includes a second surface, opposite the first surface, the second surface configured to contact a first light pipe.
Abstract: The present invention relates to methods of diagnosing a liver disorder in a patient, as well as methods of monitoring the progression of a liver disorder and/or methods of monitoring a treatment protocol of a therapeutic agent or regimen. The invention also relates to assay kits used in connection with the diagnostic methods described herein.
Abstract: The invention relates to methods for conducting solid-phase binding assays. One example is an assay method having improved analyte specificity where specificity is limited by the presence of non-specific binding interactions.
Type:
Grant
Filed:
February 11, 2021
Date of Patent:
January 2, 2024
Assignee:
MESO SCALE TECHNOLOGIES, LLC.
Inventors:
Eli N. Glezer, Sudeep Kumar, Pankaj Oberoi, George Sigal, Michael Tsionsky